Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8681 USD | +1.43% |
|
-3.01% | -2.35% |
Business Summary
Number of employees: 210
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sergio Quezada
FOU | Founder | 49 | 31/10/20 |
Karl Peggs
FOU | Founder | 57 | 31/10/20 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 31/12/17 |
Robert Coutts
DFI | Director of Finance/CFO | 40 | 31/10/20 |
Edward Samuel
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/22 |
Shree Patel
COO | Chief Operating Officer | - | - |
James Taylor
PRN | Corporate Officer/Principal | - | 30/06/22 |
Tariq Ahmed
HRO | Human Resources Officer | - | 29/02/20 |
Daniel Hood
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carsten Boess
BRD | Director/Board Member | 57 | 31/03/20 |
Edwin Moses
CHM | Chairman | 69 | - |
Director/Board Member | 69 | 03/05/22 | |
Michael Giordano
BRD | Director/Board Member | 66 | 31/08/18 |
Julie O'Neill
BRD | Director/Board Member | 58 | 02/05/21 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 31/12/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,087,901 | 40,677,022 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Achilles Therapeutics Plc
245 Hammersmith Road
W6 8PW, London
+44 20 8154 4600
http://www.achillestx.com![address Achilles Therapeutics plc(ACHL)](https://cdn.zonebourse.com/static/address/120866204.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.35% | 35.67M | |
+38.36% | 52.73B | |
+39.47% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- ACHL Stock
- Company Achilles Therapeutics plc